References
- Charitos IA, Ballini A, Cantore S, Boccellino M, Di Domenico M, Borsani E, Nocini R, Di Cosola M, Santacroce L, Bottalico L. Stem Cells: A historical review about biological, religious, and ethical issues. Stem Cells Int. 2021;2021:9978837; DOI:10.1155/2021/9978837.
- Nicolas P, Etoc F, Brivanlou AH. The ethics of human-embryoids model: a call for consistency. J Mol Med. 2021;99(4):569–79; DOI:10.1007/S00109-021-02053-7.
- Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: major challenges. J Cell Biochem. 2008;105(6):1352–60; DOI:10.1002/JCB.21957.
- Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif. 2004;37(1):23–34; DOI:10.1111/J.1365-2184.2004.00298.X.
- Biswas A, Hutchins R. Embryonic Stem Cells. 2007;16(2):213–21; DOI:10.1089/SCD.2006.0081.
- Martello G, Smith A. The nature of embryonic stem cells. 2014;30:647–75; DOI:10.1146/ANNUREV-CELLBIO-100913-013116.
- Lin G, Xie Y, OuYang Q, Qian X, Xie P, Zhou X, Xiong B, Tan Y, Li W, Deng L, Zhou J, Zhou D, Du L, Cheng D, Liao Y, Gu Y, Zhang S, Liu T, Sun Y, Lu G. HLA-matching potential of an established human embryonic Stem Cell Bank in China. Cell Stem Cell. 2009;5(5):461–5; DOI:10.1016/j.stem.2009.10.009.
- Okita K, Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc B Biol Sci. 2011;366(1575):2198–207; DOI:10.1098/RSTB.2011.0016.
- Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012;10(6):678–84; DOI:10.1016/J.STEM.2012.05.005.
- Taylor CJ, Peacock S, Chaudhry AN, Bradley JA, Bolton EM. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell. 2012;11(2):147–52; DOI:10.1016/J.STEM.2012.07.014.
- Cao S, Loh K, Pei Y, Zhang W, Han J. Overcoming barriers to the clinical utilization of iPSCs: Reprogramming efficiency, safety and quality. Protein Cell. 2012;3(11):834–45; DOI:10.1007/s13238-012-2078-6.
- Kang E, Wang X, Tippner-Hedges R, Ma H, Folmes CDL, Gutierrez NM, Lee Y, Van Dyken C, Ahmed R, Li Y, Koski A, Hayama T, Luo S, Harding CO, Amato P, Jensen J, Battaglia D, Lee D, Wu D, Terzic A, Wolf DP, Huang T, Mitalipov S. Age-Related Accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs. Cell Stem Cell. 2016;18(5):625–36; DOI:10.1016/J.STEM.2016.02.005.
- Riggs JW, Barrilleaux BL, Varlakhanova N, Bush KM, Chan V, Knoepfler PS. Induced pluripotency and oncogenic transformation are related processes. Stem Cells Dev. 2013;22(1):37–50; DOI:10.1089/SCD.2012.0375.
- Zviran A, Hanna JH. Lucky iPSCs. Genome Biol. 2014;15(3):1–5; DOI:10.1186/GB4167.
- Young HE, Black AC. Adult stem cells 2004;276(1):75–102; DOI:10.1002/ar.a.10134.
- Stefanska K, Bryl R, Moncrieff L, Pinto N, Shibli JA, Dyszkiewicz-Konwińska M. Mesenchymal stem cells - a historical overview. Med J Cell Biol. 2020;8(2):83–7; DOI:10.2478/acb-2020-0010.
- Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol. 2006;208(1):64–76; DOI:10.1002/JCP.20636.
- Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116(5):639–48; DOI:10.1016/S0092-8674(04)00208-9.
- Kim E-H, Heo CY. Current applications of adipose-derived stem cells and their future perspectives. World J Stem Cells. 2014;6(1):65–8; DOI:10.4252/WJSC.V6.I1.65.